Estramustine formulations with improved pharmaceutical...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/565 (2006.01) A61K 47/40 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2174968

The present invention provides a pharmaceutical composition comprising an estramustine derivative and a cyclodextrin, particularly in the manufacture of a medicament suitable for the oral administration of an estramustine derivative to a patient suffering from a tumor. Estramustine derivatives according to the invention are, for example, compounds of general formula (I) wherein R is (a) or (b) in which R1 is C1-C4 alkyl and n is 0, 1 or 2, and the pharmaceutically acceptable salts thereof.

On décrit une composition pharmaceutique qui comprend un dérivé d'estramustine ainsi qu'une cyclodextrine et qui est destinée notamment à la fabrication d'un médicament conçu pour l'administration orale d'un dérivé d'estramustine à un patient souffrant d'une tumeur. Des dérivés d'estramustine selon l'invention sont, par exemple, des composés de la formule générale (I) ainsi que les sels de ceux-ci, acceptables sur le plan pharmacologique, formule dans laquelle R représente (a) ou (b) où R¿1? représente alkyle C¿1?-C¿4? et n vaut 0, 1 ou 2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Estramustine formulations with improved pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estramustine formulations with improved pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estramustine formulations with improved pharmaceutical... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1478235

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.